Commercial Methods for Identification and Susceptibility Testing of Fungi

Donna M. Wolk; Glenn D. Roberts

doi:10.1128/9781555817961.ch9

Chapter 9 : Commercial Methods for Identification and Susceptibility Testing of Fungi

Authors: Donna M. Wolk, Glenn D. Roberts

Content Type: Reference

Publication Year: 2002

Category: Clinical Microbiology

Book DOI: 10.1128/9781555817961

Chapter DOI: 10.1128/9781555817961.ch9

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Commercial Methods for Identification and Susceptibility Testing of Fungi, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817961/9781555811891_Chap09-1.gif /docserver/preview/fulltext/10.1128/9781555817961/9781555811891_Chap09-2.gif

Abstract:

The methods described in this chapter are meant to represent those that are commercially available, Food and Drug Administration-approved, and published in peer-reviewed journals. The advantages of the nonautomated and automated identification systems discussed in the chapter include the fact that identification is based on databases that include a variety of substrate utilization patterns and that contain many yeast biotypes. Reproducibility was determined as results were compared in an interlaboratory study with broth macrodilution as the reference standard. In this report, the E test quality control limits were 1 dilution greater (4 dilutions overall) than those of the NCCLS broth tube macrodilution method for the following combinations: ketoconazole with C. krusei and amphotericin B and ketoconazole with C. parapsilosis. When the Premier EIA method was compared to the microimmunodiffusion (MID) test and the laboratory CF test for a total of 168 sera, including 68 from proven cases of histoplasmosis, the sensitivity of the EIA for IgG was 97%and that of the MID was 100%, and the specificities were 84 and 100%, respectively. In this study, three sera from histoplasmosis patients which were positive for the histoplasmin antigens tested negative for IgG, specific precipitins, and complement-fixing antibodies. Due to the interest in rapid, cost-effective testing for fungi, the pace and number of publications devoted to diagnostic practices in clinical mycology laboratories are growing.

Citation: Wolk D, Roberts G. 2002. Commercial Methods for Identification and Susceptibility Testing of Fungi, p 225-255. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch9

Key Concept Ranking

Antifungal Agents: 0.6274736
Fungal Infections: 0.62412024
Candida albicans: 0.5531401

0.6274736

Highlighted Text: Show | Hide

Full text loading...

Figures

Commercial Methods for Identification and Susceptibility Testing of Fungi

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817961.chap9-1,webId=/content/author/10.1128/9781555817961.chap9-1,properties={foaf_givenname=Donna M., foaf_name=Donna M. Wolk, foaf_surname=Wolk}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817961.chap9-2,webId=/content/author/10.1128/9781555817961.chap9-2,properties={foaf_givenname=Glenn D., foaf_name=Glenn D. Roberts, foaf_surname=Roberts}]]

/content/10.1128/9781555817961.chap9.fig9-1

FIGURE 1

BactiCardCandida. Courtesy of Remel.

10.1128/9781555817961/fig9-1_thmb.gif

10.1128/9781555817961/fig9-1.gif

FIGURE 1

BactiCardCandida. Courtesy of Remel.

/content/10.1128/9781555817961.chap9.fig9-2

FIGURE 2

Uni-N/F Tek and Uni-Yeast-Tek plates (uninoculated and inoculated). Courtesy of Remel.

10.1128/9781555817961/fig9-2_thmb.gif

10.1128/9781555817961/fig9-2.gif

FIGURE 2

Uni-N/F Tek and Uni-Yeast-Tek plates (uninoculated and inoculated). Courtesy of Remel.

/content/10.1128/9781555817961.chap9.fig9-3

FIGURE 3

(A) Inoculation of the API 20 C (Biomerieux Vitek) strip for identification of yeast isolates. Each strip contains microcupules containing dehydrated substrates, which are rehydrated and examined to determine their ability to support the growth of yeast isolates. (B) Close-up view of substrate utilization by a yeast isolate. Positive reactions appear cloudy in comparison to the negative (0) control.

10.1128/9781555817961/fig9-3_thmb.gif

10.1128/9781555817961/fig9-3.gif

FIGURE 3

/content/10.1128/9781555817961.chap9.fig9-4

FIGURE 4

The RapID Yeast Plus System (Innovative Diagnostic Systems and Remel).

10.1128/9781555817961/fig9-4_thmb.gif

10.1128/9781555817961/fig9-4.gif

FIGURE 4

The RapID Yeast Plus System (Innovative Diagnostic Systems and Remel).

/content/10.1128/9781555817961.chap9.fig9-5

FIGURE 5

API Yeast-Ident.

10.1128/9781555817961/fig9-5_thmb.gif

10.1128/9781555817961/fig9-5.gif

FIGURE 5

API Yeast-Ident.

/content/10.1128/9781555817961.chap9.fig9-6

FIGURE 6

Identicult-Albicans.

10.1128/9781555817961/fig9-6_thmb.gif

10.1128/9781555817961/fig9-6.gif

FIGURE 6

Identicult-Albicans.

/content/10.1128/9781555817961.chap9.fig9-7

FIGURE 7

The Microscan Rapid Yeast Identification Panel. Courtesy of Dade Microscan.

10.1128/9781555817961/fig9-7_thmb.gif

10.1128/9781555817961/fig9-7.gif

FIGURE 7

The Microscan Rapid Yeast Identification Panel. Courtesy of Dade Microscan.

References

/content/book/10.1128/9781555817961.chap9

1. Ainscough, S.,, and C. C. Kibbler. 1998. An evaluation of the cost-effectiveness of using CHROMagar for yeast identification in a routine microbiology laboratory. J. Med. Microbiol. 47: 623– 628.

2. Ansorg, R.,, E. Heintschel von Heinegg,, and P. M. Rath. 1994. Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 13: 582– 589.

3. Ansorg, R.,, R. van den Boom,, and P. M. Rath. 1997. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 40: 353– 357.

4. Arthington-Skaggs, B. A.,, M. Motley,, D. W. Warnock,, and C. J. Morrison. 2000. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts. J. Clin. Microbiol. 38: 2254– 2260.

5. Bale, M. J.,, C. Yang,, and M. A. Pfaller. 1997. Evaluation of growth characteristics on blood agar and eosin methylene blue agar for the identification of Candida (Torulopsis) glabrata. Diagn. Microbiol. Infect. Dis. 28: 65– 67.

6. Banerjee, S. N.,, T. G. Emori,, D. H. Culver,, R. P. Gaynes,, W. R. Jarvis,, T. Horan,, J. R. Edwards,, J. Tolson,, T. Henderson,, and W. J. Martone. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am. J. Med. 91: 86S– 89S.

7. Baumgartner, C.,, A. M. Freydiere,, and Y. Gille. 1996. Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J. Clin. Microbiol. 34: 454– 456.

8. Bernal, S.,, M. E. Martin,, M. Chavez,, J. Coronilla,, and A. Valverde. 1998. Evaluation of the new API Candida system for identification of the most clinically important yeast species. Diagn. Microbiol. Infect. Dis. 32: 217– 221.

9. Bernal, S.,, M. E. Martin,, M. Garcia,, A. I. Aller,, M. A. Martinez,, and M. J. Gutierrez. 1996. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn. Microbiol. Infect. Dis. 24: 201– 204.

10. Bernard, K.,, C. Cooper,, S. Tessier,, and E. P. Ewan. 1991. Use of chemotaxonomy as an aid to differentiate among Capnocytophaga species, CDC group DF-3, and aerotolerant strains of Leptotrichia buccalis. J. Clin. Microbiol. 29: 2263– 2265.

11. Bianchi, M.,, R. Negroni,, A. Robles,, A. Arechavala,, S. Helou,, and M. Corti. 1997. Comparative study of three blood culture systems for the diagnosis of systemic mycoses associated with AIDS. J. Mycol. Med. 7: 134– 136.

12. Blevins, L. B.,, J. Fenn,, H. Segal,, P. Newcomb-Gayman,, and K. C. Carroll. 1995. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J. Clin. Microbiol. 33: 1674– 1675.

13. Boschman, C. R.,, L. J. Tucker,, D. C. Dressel,, C. C. Novak,, R. T. Hayden,, and L. R. Peterson. 1995. Optimizing detection of microbial sepsis: a comparison of culture systems using packaged sets with directions for blood collection. Diagn. Microbiol. Infect. Dis. 23: 1– 9.

14. Bougnoux, M. E.,, C. Hill,, D. Moissenet,, D. C. Feuilhade,, M. Bonnay,, I. Vicens-Sprauel,, F. Pietri,, M. McNeil,, L. Kaufman,, and J. Dupouy-Camet. 1990. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J. Clin. Microbiol. 28: 905– 909.

15. Buchaille, L.,, A. M. Freydiere,, R. Guinet,, and Y. Gille. 1998. Evaluation of six commercial systems for identification of medically important yeasts. Eur. J. Clin. Microbiol. Infect. Dis. 17: 479– 488.

16. Cabezudo, I.,, M. Pfaller,, T. Gerarden,, F. Koontz,, R. Wenzel,, R. Gingrich,, K. Heckman,, and C. P. Burns. 1989. Value of the Cand-Tec Candida antigen assay in the diagnosis and therapy of systemic candidiasis in high-risk patients. Eur. J. Clin. Microbiol. Infect. Dis. 8: 770– 777.

17. Campbell, C. K.,, K. G. Davey,, A. D. Holmes,, A. Szekely,, and D. W. Warnock. 1999. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J. Clin. Microbiol. 37: 821– 823.

18. Campbell, C. K.,, A. D. Holmes,, K. G. Davey,, A. Szekely,, and D. W. Warnock. 1998. Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 17: 367– 368.

19. Carlson, P.,, M. Richardson,, and J. Paavonen. 2000. Evaluation of the Oricult-N dipslide for laboratory diagnosis of vaginal candidiasis. J. Clin. Microbiol. 38: 1063– 1065.

20. Christensson, B.,, G. Sigmundsdottir,, and L. Larsson. 1999. D-Arabinitol—a marker for invasive candidiasis. Med. Mycol. 37: 391– 396.

21. Cockerill, F. R., III, C. A. Torgerson, G. S. Reed, E. A. Vetter, A. L. Weaver, J. C. Dale, G. D. Roberts, N. K. Henry, D. M. Ilstrup, and J. E. Rosenblatt. 1996. Clinical comparison of Difco ESP, Wampole Isolator, and Becton Dickinson Septi-Chek aerobic blood culturing systems. J. Clin. Microbiol. 34: 20– 24.

22. Colombo, A. L.,, F. Barchiesi,, D. A. McGough,, and M. G. Rinaldi. 1995. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. J. Clin. Microbiol. 33: 535– 540.

23. Cornish, N.,, B. A. Kirkley,, K. A. Easley,, and J. A. Washington. 1998. Reassessment of the incubation time in a controlled clinical comparison of the BacT/Alert aerobic FAN bottle and standard anaerobic bottle used aerobically for the detection of bloodstream infections. Diagn. Microbiol. Infect. Dis. 32: 1– 7.

24. Creger, R. J.,, K. E. Weeman,, M. R. Jacobs,, A. Morrissey,, P. Parker,, R. M. Fox,, and H. M. Lazarus. 1998. Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients. J. Clin. Microbiol. 36: 290– 293.

25. Crist, A. E., Jr.,, T. J. Dietz,, and K. Kampschroer. 1996. Comparison of the MUREX C. albicans, Albicans-Sure, and BactiCard Candida test kits with the germ tube test for presumptive identification of Candida albicans. J. Clin. Microbiol. 34: 2616– 2618.

26. Crist, A. E., Jr.,, L. M. Johnson,, and P. J. Burke. 1996. Evaluation of the Microbial Identification System for identification of clinically isolated yeasts. J. Clin. Microbiol. 34: 2408– 2410.

27. D’Amato, R. F.,, L. Hochstein,, and E. A. Fay. 1990. False-positive latex agglutination test for Neisseria meningitidis groups A and Y caused by povidone-iodine antiseptic contamination of cerebrospinal fluid. J. Clin. Microbiol. 28: 2134– 2135.

28. Dannaoui, E.,, S. Colin,, J. Pichot,, and M. A. Piens. 1997. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 16: 228– 232.

29. Davey, K. G.,, P. M. Chant,, C. S. Downer,, C. K. Campbell,, and D. W. Warnock. 1995. Evaluation of the AUXACOLOR system, a new method of clinical yeast identification. J. Clin. Pathol. 48: 807– 809.

30. Davey, K. G.,, A. D. Holmes,, E. M. Johnson,, A. Szekely,, and D. W. Warnock. 1998. Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J. Clin. Microbiol. 36: 926– 930.

31. Dooley, D. P.,, M. L. Beckius,, and B. S. Jeffrey. 1994. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card. J. Clin. Microbiol. 32: 2889– 2892.

32. Druetta, A.,, A. Freydiere,, R. Guinet,, and Y. Gille. 1993. Evaluation of five commercial antifungal susceptibility testing systems. Eur. J. Clin. Microbiol. Infect. Dis. 12: 336– 342.

33. el Zaatari, M.,, L. Pasarell,, M. R. McGinnis,, J. Buckner,, G. A. Land,, and I. F. Salkin. 1990. Evaluation of the updated Vitek yeast identification data base. J. Clin. Microbiol. 28: 1938– 1941.

34. Engler, H. D.,, and Y. R. Shea. 1994. Effect of potential interference factors on performance of enzyme immunoassay and latex agglutination assay for cryptococcal antigen. J. Clin. Microbiol. 32: 2307– 2308.

35. Espinel-Ingroff, A.,, T. M. Kerkering,, P. R. Goldson,, and S. Shadomy. 1991. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 29: 1089– 1094.

36. Espinel-Ingroff, A.,, C. W. Kish, Jr.,, T. M. Kerkering,, R. A. Fromtling,, K. Bartizal,, J. N. Galgiani,, K. Villareal,, M. A. Pfaller,, T. Gerarden,, M. G. Rinaldi,, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30: 3138– 3145.

37. Espinel-Ingroff, A.,, M. Pfaller,, M. E. Erwin,, and R. N. Jones. 1996. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose. J. Clin. Microbiol. 34: 848– 852.

38. Espinel-Ingroff, A.,, M. Pfaller,, S. A. Messer,, C. C. Knapp,, S. Killian,, H. A. Norris,, and M. A. Ghannoum. 1999. Multicenter comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeastlike organisms. J. Clin. Microbiol. 37: 591– 595.

39. Espinel-Ingroff, A.,, J. L. Rodriguez-Tudela,, and J. V. Martinez-Suarez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33: 3154– 3158.

40. Espinel-Ingroff, A.,, L. Stockman,, G. Roberts,, D. Pincus,, J. Pollack,, and J. Marler. 1998. Comparison of RapID Yeast Plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J. Clin. Microbiol. 36: 883– 886.

41. Favel, A.,, C. Chastin,, A. L. Thomet,, P. Regli,, A. Michel-Nguyen,, and A. Penaud. 2000. Evaluation of the E test for antifungal susceptibility testing of Candida glabrata. Eur. J. Clin. Microbiol. Infect. Dis. 19: 146– 148.

42. Fenn, J. P.,, E. Billetdeaux,, H. Segal,, L. Skodack-Jones,, P. E. Padilla,, M. Bale,, and K. Carroll. 1999. Comparison of four methodologies for rapid and costeffective identification of Candida glabrata. J. Clin. Microbiol. 37: 3387– 3389.

43. Fenn, J. P.,, H. Segal,, B. Barland,, D. Denton,, J. Whisenant,, H. Chun,, K. Christofferson,, L. Hamilton,, and K. Carroll. 1994. Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J. Clin. Microbiol. 32: 1184– 1187.

44. Fenn, J. P.,, H. Segal,, L. Blevins,, S. Fawson,, P. Newcomb-Gayman,, and K. C. Carroll. 1996. Comparison of the Murex Candida albicans CA50 test with germ tube production for identification of C. albicans. Diagn. Microbiol. Infect. Dis. 24: 31– 35.

45. Frank, U. K.,, S. L. Nishimura,, N. C. Li,, K. Sugai,, D. M. Yajko,, W. K. Hadley,, and V. L. Ng. 1993. Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid. J. Clin. Microbiol. 31: 97– 101.

46. Fraser, V. J.,, M. Jones,, J. Dunkel,, S. Storfer,, G. Medoff,, and W. C. Dunagan. 1992. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15: 414– 421.

47. Freydiere, A. M.,, L. Buchaille,, and Y. Gille. 1997. Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens. Eur. J. Clin. Microbiol. Infect. Dis. 16: 464– 467.

48. Freydiere, A. M.,, L. Buchaille,, R. Guinet,, and Y. Gille. 1997. Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies. J. Clin. Microbiol. 35: 877– 880.

49. Fricker-Hidalgo, H.,, F. Chazot,, B. Lebeau,, H. Pelloux,, P. Ambroise-Thomas,, and R. Grillot. 1998. Use of simulated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection. Eur. J. Clin. Microbiol. Infect. Dis. 17: 113– 116.

50. Fricker-Hidalgo, H.,, A. Chirpaz-Cerbat,, B. Lebeau,, P. Ambroise-Thomas,, and R. Grillot. 1997. Evaluation of Bactec 9240 blood culture system by using the aerobic 9240 medium for fungemia detection. J. Mycol. Med. 7: 128– 133.

51. Fricker-Hidalgo, H.,, B. Lebeau,, P. Kervroedan,, O. Faure,, P. Ambroise-Thomas,, and R. Grillot. 1995. Auxacolor, a new commercial system for yeast identification: evaluation of 182 strains comparatively with ID 32C. Ann. Biol. Clin. (Paris) 53: 221– 225.

52. Fricker-Hidalgo, H.,, O. Vandapel,, M. A. Duchesne,, M. A. Mazoyer,, D. Monget,, B. Lardy,, B. Lebeau,, J. Freney,, P. Ambroise-Thomas,, and R. Grillot. 1996. Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species. J. Clin. Microbiol. 34: 1846– 1848.

53. Fromtling, R. A.,, J. N. Galgiani,, M. A. Pfaller,, A. Espinel-Ingroff,, K. F. Bartizal,, M. S. Bartlett,, B. A. Body,, C. Frey,, G. Hall,, and G. D. Roberts. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37: 39– 45.

54. Gade, W.,, S. W. Hinnefeld,, L. S. Babcock,, P. Gilligan,, W. Kelly,, K. Wait,, D. Greer,, M. Pinilla,, and R. L. Kaplan. 1991. Comparison of the PREMIER cryptococcal antigen enzyme immunoassay and the latex agglutination assay for detection of cryptococcal antigens. J. Clin. Microbiol. 29: 1616– 1619.

55. Gales, A. C.,, M. A. Pfaller,, A. K. Houston,, S. Joly,, D. J. Sullivan,, D. C. Coleman,, and D. R. Soll. 1999. Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha- methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems. J. Clin. Microbiol. 37: 3804– 3808.

56. Garcia-Prats, J. A.,, T. R. Cooper,, V. F. Schneider,, C. E. Stager,, and T. N. Hansen. 2000. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 105: 523– 527.

57. Geha, D. J.,, and G. D. Roberts. 1994. Laboratory detection of fungemia. Clin. Lab. Med. 14: 83– 97.

58. Goldschmidt, M. C.,, D. Y. Fung,, R. Grant,, J. White,, and T. Brown. 1991. New aniline blue dye medium for rapid identification and isolation of Candida albicans. J. Clin. Microbiol. 29: 1095– 1099.

59. Graf, B.,, T. Adam,, E. Zill,, and U. B. Gobel. 2000. Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms. J. Clin. Microbiol. 38: 1782– 1785.

60. Gray, L. D.,, and G. D. Roberts. 1988. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J. Clin. Microbiol. 26: 2450– 2451.

61. Gromadzki, S. G.,, and V. Chaturvedi. 2000. Limitation of the AccuProbe Coccidioides immitis culture identification test: false-negative results with formaldehydekilled cultures. J. Clin. Microbiol. 38: 2427– 2428.

62. Guerra-Romero, L.,, R. S. Edson,, F. R. Cockerill III,, C. D. Horstmeier,, and G. D. Roberts. 1987. Comparison of Du Pont Isolator and Roche Septi- Chek for detection of fungemia. J. Clin. Microbiol. 25: 1623– 1625.

63. Gutierrez, J.,, C. Maroto,, G. Piedrola,, E. Martin,, and J. A. Perez. 1993. Circulating Candida antigens and antibodies: useful markers of candidemia. J. Clin. Microbiol. 31: 2550– 2552.

64. Gutierrez, J.,, E. Martin,, C. Lozano,, J. Coronilla,, and C. Nogales. 1994. Evaluation of the ATB 32C automicrobic system and API 20C using clinical yeast isolates. Ann. Biol. Clin. (Paris) 52: 443– 446.

65. Hall, G. S.,, K. Pratt-Rippin,, and J. A. Washington. 1992. Evaluation of a chemiluminescent probe assay for identification of Histoplasma capsulatum isolates. J. Clin. Microbiol. 30: 3003– 3004.

66. Hamilton, J. R.,, A. Noble,, D. W. Denning,, and D. A. Stevens. 1991. Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment. J. Clin. Microbiol. 29: 333– 339.

67. Hantschke, D. 2000. Differentiation of yeast-like fungi using the commercial Auxacolor system. Mycoses 39: 135– 140.

68. Hashiguchi, K.,, H. Wada,, O. Yamada,, Y. Yawata,, K. Yoshida,, J. Okimoto,, S. Umeki,, Y. Niki,, and R. Soejima. 1992. A case of chronic myelogenous leukemia with pulmonary aspergillosis diagnosed by the detection of circulating Aspergillus antigen. Kansenshogaku Zasshi 66: 1592– 1596. (In Japanese.)

69. Heelan, J. S.,, L. Corpus,, and N. Kessimian. 1991. False-positive reactions in the latex agglutination test for Cryptococcus neoformans antigen. J. Clin. Microbiol. 29: 1260– 1261. ( Erratum, 29:2091).

70. Heelan, J. S.,, D. Siliezar,, and K. Coon. 1996. Comparison of rapid testing methods for enzyme production with the germ tube method for presumptive identification of Candida albicans. J. Clin. Microbiol. 34: 2847– 2849.

71. Heelan, J. S.,, E. Sotomayor,, K. Coon,, and J. B. D’Arezzo. 1998. Comparison of the rapid yeast plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species. J. Clin. Microbiol. 36: 1443– 1445.

72. Herent, P.,, D. Stynen,, F. Hernando,, J. Fruit,, and D. Poulain. 1992. Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis. J. Clin. Microbiol. 30: 2158– 2164.

73. Hoppe, J. E.,, and P. Frey. 1999. Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 18: 188– 191.

74. Hopwood, V.,, E. M. Johnson,, J. M. Cornish,, A. B. Foot,, E. G. Evans,, and D. W. Warnock. 1995. Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J. Clin. Pathol. 48: 210– 213.

75. Hossain, M. A.,, T. Miyazaki,, K. Mitsutake,, H. Kakeya,, Y. Yamamoto,, K. Yanagihara,, S. Kawamura,, T. Otsubo,, Y. Hirakata,, T. Tashiro,, and S. Kohno. 1997. Comparison between Wako-WB003 and Fungitec G tests for detection of (1→3)-beta-D-glucan in systemic mycosis. J. Clin. Lab. Anal. 11: 73– 77.

76. Huffnagle, K. E.,, and R. M. Gander. 1993. Evaluation of Gen-Probe’s Histoplasma capsulatum and Cryptococcus neoformans AccuProbes. J. Clin. Microbiol. 31: 419– 421.

77. Jahn, B.,, A. Stuben,, and S. Bhakdi. 1996. Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests. J. Clin. Microbiol. 34: 2039– 2041.

78. Kami, M.,, Y. Kanda,, S. Ogawa,, S. Mori,, Y. Tanaka,, H. Honda,, S. Chiba,, K. Mitani,, Y. Yazaki,, and H. Hirai. 1999. Frequent false-positive results of Aspergillus latex agglutination test: transient Aspergillus antigenemia during neutropenia. Cancer 86: 274– 281.

79. Kaufman, L.,, J. A. Kovacs,, and E. Reiss,. 1997. Clinical immunomycology, p. 585– 604. In N. R. Rose,, E. C. de Macario,, J. D. Folds,, H. C. Lane,, and R. M. Nakamura (ed.), Manual of Clinical Laboratory Immunology. ASM Press, Washington, D.C..

80. Kaufman, L.,, A. S. Sekhon,, N. Moledina,, M. Jalbert,, and D. Pappagianis. 1995. Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J. Clin. Microbiol. 33: 618– 619.

81. Kellogg, J. A.,, D. A. Bankert,, and V. Chaturvedi. 1998. Limitations of the current microbial identification system for identification of clinical yeast isolates. J. Clin. Microbiol. 36: 1197– 1200.

82. Kellogg, J. A.,, D. A. Bankert,, and V. Chaturvedi. 1999. Variation in Microbial Identification System accuracy for yeast identification depending on commercial source of Sabouraud dextrose agar. J. Clin. Microbiol. 37: 2080– 2083.

83. Kellogg, J. A.,, D. A. Bankert,, J. P. Manzella,, K. S. Parsey,, S. L. Scott,, and S. H. Cavanaugh. 1994. Clinical comparison of Isolator and thiol broth with ESP aerobic and anaerobic bottles for recovery of pathogens from blood. J. Clin. Microbiol. 32: 2050– 2055.

84. Kirkley, B. A.,, K. A. Easley,, and J. A. Washington. 1994. Controlled clinical evaluation of Isolator and ESP aerobic blood culture systems for detection of bloodstream infections. J. Clin. Microbiol. 32: 1547– 1549.

85. Kiska, D. L.,, D. R. Orkiszewski,, D. Howell,, and P. H. Gilligan. 1994. Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid. J. Clin. Microbiol. 32: 2309– 2311.

86. Kitch, T. T.,, M. R. Jacobs,, M. R. McGinnis,, and P. C. Appelbaum. 1996. Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours. J. Clin. Microbiol. 34: 1069– 1071.

87. Land, G.,, J. Burke,, C. Shelby,, J. Rhodes,, J. Collett,, I. Bennett,, and J. Johnson. 1996. Screening protocol for Torulopsis (Candida) glabrata. J. Clin. Microbiol. 34: 2300– 2303.

88. Land, G. A.,, I. F. Salkin,, M. el Zaatari,, M. R. McGinnis,, and G. Hashem. 1991. Evaluation of the Baxter- MicroScan 4-hour enzyme-based yeast identification system. J. Clin. Microbiol. 29: 718– 722.

89. Lipperheide, V.,, L. Andraka,, J. Ponton,, and G. Quindos. 1993. Evaluation of the albicans IDR plate method for the rapid identification of Candida albicans. Mycoses 36: 417– 420.

90. Lopez-Jodra, O.,, J. M. Torres-Rodriguez,, R. Mendez-Vasquez,, E. Ribas-Forcadell,, Y. Morera-Lopez,, T. Baro-Tomas,, and C. Alia-Aponte. 2000. In vitro susceptibility of cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J. Antimicrob. Chemother. 45: 645– 649.

91. Lozano-Chiu, M.,, M. V. Lancaster,, and J. H. Rex. 1998. Evaluation of a colorimetric method for detecting amphotericin B-resistant Candida isolates. Diagn. Microbiol. Infect. Dis. 31: 417– 424.

92. Lyon, R.,, and G. Woods. 1995. Comparison of the BacT/Alert and Isolator blood culture systems for recovery of fungi. Am. J. Clin. Pathol. 103: 660– 662.

93. Manso, E.,, M. Montillo,, G. De Sio,, S. D’Amico,, G. Discepoli,, and P. Leoni. 1994. Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies. Eur. J. Clin. Microbiol. Infect. Dis. 13: 756– 760.

94. Marcelis, L.,, J. Verhaegen,, J. Vandeven,, A. Bosmans,, and L. Verbist. 1992. Evaluation of Bactec high blood volume resin media. Diagn. Microbiol. Infect. Dis. 15: 385– 391.

95. Martins, T. B.,, T. D. Jaskowski,, C. L. Mouritsen,, and H. R. Hill. 1995. Comparison of commercially available enzyme immunoassay with traditional serological tests for detection of antibodies to Coccidioides immitis. J. Clin. Microbiol. 33: 940– 943.

96. Merz, W. G.,, and G. D. Roberts,. 1999. Algorithms for detection and identification of fungi, p. 1167– 1183. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover,, and R. H. Yolken (ed.), Manual of Clinical Microbiology. ASM Press, Washington, D.C..

97. Messer, S. A.,, and M. A. Pfaller. 1996. Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testing. Diagn. Microbiol. Infect. Dis. 25: 77– 81.

98. Michel-Nguyen, A.,, A. Favel,, C. Chastin,, M. Selva,, and P. Regli. 2000. Comparative evaluation of a commercial system for identification of Candida lusitaniae. Eur. J. Clin. Microbiol. Infect. Dis. 19: 393– 395.

99. Milan, E. P.,, E. S. Malheiros,, O. Fischman,, and A. L. Colombo. 1997. Evaluation of the AUXACOLOR system for the identification of clinical yeast isolates. Mycopathologia 137: 153– 157.

100. Mitsutake, K.,, T. Miyazaki,, T. Tashiro,, Y. Yamamoto,, H. Kakeya,, T. Otsubo,, S. Kawamura,, M. A. Hossain,, Y. Hirakata,, and S. Kohno. 1996. Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J. Clin. Microbiol. 34: 1918– 1921.

101. Moghaddas, J.,, A. L. Truant,, C. Jordan,, and H. R. Buckley. 1999. Evaluation of the RapID Yeast Plus System for the identification of yeast. Diagn. Microbiol. Infect. Dis. 35: 271– 273.

102. Morello, J. A.,, C. Leitch,, S. Nitz,, J. W. Dyke,, M. Andruszewski,, G. Maier,, W. Landau,, and M. A. Beard. 1994. Detection of bacteremia by Difco ESP blood culture system. J. Clin. Microbiol. 32: 811– 818.

103. Mori, T.,, H. Ikemoto,, M. Matsumura,, M. Yoshida,, K. Inada,, S. Endo,, A. Ito,, S. Watanabe,, H. Yamaguchi,, M. Mitsuya,, M. Kodama,, T. Tani,, T. Yokota,, T. Kobayashi,, J. Kambayashi,, T. Nakamura,, T. Masaoka,, H. Teshima,, T. Yoshinaga,, S. Kohno,, K. Hara,, and S. Miyazaki. 1997. Evaluation of plasma (1→3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur. J. Clin. Chem. Clin. Biochem. 35: 553– 560.

104. Morrell, R. M., Jr.,, and B. L. Wasilauskas. 1992. Tracking laboratory contamination by using a Bacillus cereus pseudoepidemic as an example. J. Clin. Microbiol. 30: 1469– 1473.

105. Morrell, R. M., Jr.,, B. L. Wasilauskas,, and C. H. Steffee. 1996. Performance of fungal blood cultures by using the Isolator collection system: is it cost-effective? J. Clin. Microbiol. 34: 3040– 3043.

106. Murray, P. R. 1991. Comparison of the lysis-centrifugation and agitated biphasic blood culture systems for detection of fungemia. J. Clin. Microbiol. 29: 96– 98.

107. Musial, C. E.,, F. R. Cockerill III,, and G. D. Roberts. 1988. Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin. Microbiol. Rev. 1: 349– 364.

108. Muta, T.,, and S. Iwanaga. 1996. Clotting and immune defense in Limulidae. Prog. Mol. Subcell. Biol. 15: 154– 189.

109. Nakao, A.,, M. Yasui,, T. Kawagoe,, H. Tamura,, S. Tanaka,, and H. Takagi. 1997. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepato-Gastroenterology 44: 1413– 1418.

110. Ness, M. J.,, W. P. Vaughan,, and G. L. Woods. 1989. Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients. J. Infect. Dis. 159: 495– 502.

111. Niki, Y. 1996. Sero-diagnosis for pulmonary aspergillosis—its utility in early diagnosis. Rinsho Byori 44: 518– 523. (In Japanese.)

112. Odds, F. C.,, and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32: 1923– 1929.

113. Odds, F. C.,, L. Vranckx,, and F. Woestenborghs. 1995. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob. Agents Chemother. 39: 2051– 2060.

114. Padhye, A. A.,, G. Smith,, D. McLaughlin,, P. G. Standard,, and L. Kaufman. 1992. Comparative evaluation of a chemiluminescent DNA probe and an exoantigen test for rapid identification of Histoplasma capsulatum. J. Clin. Microbiol. 30: 3108– 3111.

115. Patterson, T. F.,, W. R. Kirkpatrick,, S. G. Revankar,, R. K. McAtee,, A. W. Fothergill,, D. I. McCarthy,, and M. G. Rinaldi. 1996. Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans. J. Clin. Microbiol. 34: 3237– 3239.

116. Paugam, A.,, M. Benchetrit,, A. Fiacre,, C. Tourte-Schaefer,, and J. Dupouy-Camet. 1999. Comparison of four commercialized biochemical systems for clinical yeast identification by colour-producing reactions. Med. Mycol. 37: 11– 17.

117. Perry, J. L.,, and G. R. Miller. 1987. Umbelliferyl-labeled galactosaminide as an aid in identification of Candida albicans. J. Clin. Microbiol. 25: 2424– 2425.

118. Perry, J. L.,, G. R. Miller,, and D. L. Carr. 1990. Rapid, colorimetric identification of Candida albicans. J. Clin. Microbiol. 28: 614– 615.

119. Petti, C. A.,, A. K. Zaidi,, S. Mirrett,, and L. B. Reller. 1996. Comparison of Isolator 1.5 and BACTEC NR660 aerobic 6A blood culture systems for detection of fungemia in children. J. Clin. Microbiol. 34: 1877– 1879.

120. Pfaller, M. A.,, S. Arikan,, M. Lozano-Chiu,, Y. Chen,, S. Coffman,, S. A. Messer,, R. Rennie,, C. Sand,, T. Heffner,, J. H. Rex,, J. Wang,, and N. Yamane. 1998. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing. J. Clin. Microbiol. 36: 2609– 2612.

121. Pfaller, M. A.,, and A. L. Barry. 1994. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 32: 1992– 1996.

122. Pfaller, M. A.,, I. Cabezudo,, B. Buschelman,, M. Bale,, T. Howe,, M. Vitug,, H. J. Linton,, and M. Densel. 1993. Value of the Hybritech ICON Candida Assay in the diagnosis of invasive candidiasis in high-risk patients. Diagn. Microbiol. Infect. Dis. 16: 53– 60.

123. Pfaller, M. A.,, S. A. Messer,, and A. Bolmstrom. 1998. Evaluation of E test for determining in vitro susceptibility of yeast isolates to amphotericin B. Diagn. Microbiol. Infect. Dis. 32: 223– 227.

124. Pfaller, M. A.,, S. A. Messer,, A. Bolmström,, F. C. Odds,, and J. H. Rex. 1996. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 34: 1691– 1693.

125. Pfaller, , M. A.,, S. A. Messer, Å . Karlsson, and A. Bolmström. 1998. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J. Clin. Microbiol. 36: 2586– 2589.

126. Pfaller, M. A.,, J. H. Rex,, and M. G. Rinaldi. 1997. Antifungal susceptibility testing: technical advances and potential clinical applications. Clin. Infect. Dis. 24: 776– 784.

127. Powell, H. L.,, C. A. Sand,, and R. P. Rennie. 1998. Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species. Diagn. Microbiol. Infect. Dis. 32: 201– 204.

128. Procop, G. W.,, and G. D. Roberts,. 1998. Laboratory methods in basic mycology, p. 871– 951. In B. A. Forbes,, D. F. Sahm,, and A. S. Weissfeld> (ed.), Bailey & Scott’s Diagnostic Microbiology. Mosby, Inc., St. Louis, Mo..

129. Qian, Q.,, I. Sinkeldam,, and G. D. Roberts. 1999. Comparison of a colorimetric microdilution method and the NNCLS macrodilution method for antifungal susceptibility testing of yeasts. J. Mycol. Med. 9: 181– 184.

130. Quindos, G.,, V. Lipperheide,, and J. Ponton. 1993. Evaluation of two commercialized systems for the rapid identification of medically important yeasts. Mycoses 36: 299– 303.

131. Quindos, G.,, R. Salesa,, A. J. Carrillo-Munoz,, V. Lipperheide,, L. Jaudenes,, R. San Millan,, J. M. Torres-Rodriguez,, and J. Ponton. 1994. Multicenter evaluation of ATB fungus: a standardized micromethod for yeast susceptibility testing. Chemotherapy 40: 245– 251.

132. Quindos, G.,, R. San Millan,, R. Robert,, C. Bernard,, and J. Ponton. 1997. Evaluation of Bichro-latex Albicans, a new method for rapid identification of Candida albicans. J. Clin. Microbiol. 35: 1263– 1265.

133. Ramani, R.,, S. Gromadzki,, D. H. Pincus,, I. F. Salkin,, and V. Chaturvedi. 1998. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J. Clin. Microbiol. 36: 3396– 3398.

134. Rath, P. M.,, R. Oeffelke,, K. D. Muller,, and R. Ansorg. 1996. Non-value of Aspergillus antigen detection in bronchoalveolar lavage fluids of patients undergoing bone marrow transplantation. Mycoses 39: 367– 370.

135. Reiss, E.,, T. Obayashi,, K. Orle,, M. Yashida,, and R. M. Zancopé-Oliveira. 2000. Non-culture based diagnostic tests for mycotic infections. Med. Mycol. 38(Suppl. 1): 147– 159.

136. Riddle, D. L.,, O. Giger,, L. Miller,, G. S. Hall,, and G. L. Woods. 1994. Clinical comparison of the Baxter MicroScan Yeast Identification Panel and the Vitek Yeast Biochemical Card. Am. J. Clin. Pathol. 101: 438– 442.

137. Romney, M. G.,, E. A. Bryce,, R. P. Rennie,, and C. A. Sand. 2000. Rapid identification of clinical yeast isolates using the colorimetric AUXACOLOR system. Diagn. Microbiol. Infect. Dis. 36: 137– 138.

138. Rousselle, P.,, A. M. Freydiere,, P. J. Couillerot,, H. de Montclos,, and Y. Gille. 1994. Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates. J. Clin. Microbiol. 32: 3034– 3036.

139. Sanati, H.,, S. A. Messer,, M. Pfaller,, M. Witt,, R. Larsen,, A. Espinel-Ingroff,, and M. Ghannoum. 1996. Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole. J. Clin. Microbiol. 34: 1280– 1282.

140. Sanchez-Sousa, A.,, M. E. Alvarez,, L. Matz,, H. Escobar,, and F. Baquero. 1999. Aspergillus fumigatus susceptibility testing by colorimetric microdilution. J. Mycol. Med. 9: 103– 106.

141. Sand, C.,, and R. P. Rennie. 1999. Comparison of three commercial systems for the identification of germ-tube negative yeast species isolated from clinical specimens. Diagn. Microbiol. Infect. Dis. 33: 223– 229.

142. San Millan, R.,, L. Ribacoba,, J. Ponton,, and G. Quindos. 1996. Evaluation of a commercial medium for identification of Candida species. Eur. J. Clin. Microbiol. Infect. Dis. 15: 153– 158.

143. Schoofs, A.,, F. C. Odds,, R. Colebunders,, M. Ieven,, and H. Goossens. 1997. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 16: 296– 300.

144. Schuffenecker, I.,, A. Freydiere,, H. de Montclos,, and Y. Gille. 1993. Evaluation of four commercial systems for identification of medically important yeasts. Eur. J. Clin. Microbiol. Infect. Dis. 12: 255– 260.

145. Schwabe, L. D.,, E. L. Randall,, R. Miller-Catchpole,, C. I. Squires,, and R. L. Gottschall. 1990. A comparison of oxoid signal with nonradiometric BACTEC NR-660 for detection of bacteremia. Diagn. Microbiol. Infect. Dis. 13: 3– 8.

146. Sekhon, A. S.,, L. Kaufman,, G. S. Kobayashi,, N. Moledina,, M. Jalbert,, and R. H. Notenboom. 1994. Comparative evaluation of the Premier enzyme immunoassay, micro- immunodiffusion and complement fixation tests for the detection of Histoplasma capsulatum var. capsulatum antibodies. Mycoses 37: 313– 316.

147. Sekhon, A. S.,, L. Kaufman,, G. S. Kobayashi,, N. H. Moledina,, and M. Jalbert. 1995. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J. Med. Vet. Mycol. 33: 123– 125.

148. Sekhon, A. S.,, P. G. Standard,, L. Kaufman,, and A. K. Garg. 1987. Evaluation of commercial serologic test reagents for immunoidentification of medically important aspergilli. Diagn. Microbiol. Infect. Dis. 8: 183– 187.

149. Sewell, D. L.,, M. A. Pfaller,, and A. L. Barry. 1994. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. J. Clin. Microbiol. 32: 2099– 2102.

150. Sigler, L.,, and M. J. Kennedy,. 1999. Aspergillus, Fusarium, and other opportunistic moniliaceous fungi, p. 1212– 1241. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover,, and R. H. Yolken (ed.), Manual of Clinical Microbiology. ASM Press, Washington, D.C..

151. Simor, A. E.,, G. Goswell,, L. Louie,, M. Lee,, and M. Louie. 1997. Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test. Eur. J. Clin. Microbiol. Infect. Dis. 16: 693– 697.

152.St. Germain, G., and D. Beauchesne. 1991. Evaluation of the MicroScan Rapid Yeast Identification panel. J. Clin. Microbiol. 29: 2296– 2299.

153. Stockman, L.,, K. A. Clark,, J. M. Hunt,, and G. D. Roberts. 1993. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J. Clin. Microbiol. 31: 845– 850.

154. Stockman, L.,, and G. D. Roberts. 1983. Specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors. J. Clin. Microbiol. 17: 945– 947.

155. Sugar, A. M.,, and X. Liu. 1995. Comparison of three methods of antifungal susceptibility testing with the proposed NCCLS standard broth macrodilution assay: lack of effect of phenol red. National Committee for Clinical Laboratory Standards. Diagn. Microbiol. Infect. Dis. 21: 129– 133.

156. Sulahian, A.,, M. Tabouret,, P. Ribaud,, J. Sarfati,, E. Gluckman,, J. P. Latge,, and F. Derouin. 1996. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 15: 139– 145.

157. Szekely, A.,, E. M. Johnson,, and D. W. Warnock. 1999. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J. Clin. Microbiol. 37: 1480– 1483.

158. Tanner, D. C.,, M. P. Weinstein,, B. Fedorciw,, K. L. Joho,, J. J. Thorpe,, and L. Reller. 1994. Comparison of commercial kits for detection of cryptococcal antigen. J. Clin. Microbiol. 32: 1680– 1684.

159. Telenti, A.,, and G. D. Roberts. 1989. Fungal blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 8: 825– 831.

160. Tintelnot, K.,, G. Haase,, M. Seibold,, F. Bergmann,, M. Staemmler,, T. Franz,, and D. Naumann. 2000. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J. Clin. Microbiol. 38: 1599– 1608.

161. To, W. K.,, A. W. Fothergill,, and M. G. Rinaldi. 1995. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 33: 2660– 2664.

162. Valasco-Martinez, J. J.,, P. Marti-Belda,, A. Guerrero-Espejo,, A. Sanchez-Sousa,, and F. Baquero. 1995. Monoclonal/polyclonal antibodies and pronase in detection of Cryptococcal antigen in serum and cerebrospinal fluid. J. Mycol. Med. 5: 230– 234.

163. Verweij, P. E.,, A. J. Rijs,, B. E. De Pauw,, A. M. Horrevorts,, J. A. Hoogkamp-Korstanje,, and J. F. Meis. 1995. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J. Clin. Pathol. 48: 474– 476.

164. Verwij, P. E.,, I. M. Breuker,, A. J. M. M. Rijs,, and J. F. G. M. Meis. 1999. Comparative study of seven commercial yeast identification systems. J. Clin. Pathol. 52: 271– 273.

165. Wadlin, J. K.,, G. Hanko,, R. Stewart,, J. Pape,, and I. Nachamkin. 1999. Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory. J. Clin. Microbiol. 37: 1967– 1970.

166. Waite, R. T.,, and G. L. Woods. 1998. Evaluation of BACTEC MYCO/F lytic medium for recovery of mycobacteria and fungi from blood. J. Clin. Microbiol. 36: 1176– 1179.

167. Walsh, T. J.,, J. W. Hathorn,, J. D. Sobel,, W. G. Merz,, V. Sanchez,, S. M. Maret,, H. R. Buckley,, M. A. Pfaller,, R. Schaufele,, and C. Sliva. 1991. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 324: 1026– 1031.

168. Warren, N. G.,, and K. C. Hazen,. 1999. Candida, Cryptococcus, and other yeasts of medical importance, p. 1184– 1199. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover,, and R. H. Yolken (ed.), Manual of Clinical Microbiology, 7th ed. ASM Press, Washington, D.C..

169. Weinstein, M. P.,, S. Mirrett,, L. G. Reimer,, M. L. Wilson,, S. Smith-Elekes,, C. R. Chuard,, K. L. Joho,, and L. B. Reller. 1995. Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia. J. Clin. Microbiol. 33: 978– 981.

170. Wilson, M. L.,, T. E. Davis,, S. Mirrett,, J. Reynolds,, D. Fuller,, S. D. Allen,, K. K. Flint,, F. Koontz,, and L. B. Reller. 1993. Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter Isolator blood culture system for detection of fungemia and bacteremia. J. Clin. Microbiol. 31: 865– 871.

171. Wilson, M. L.,, M. P. Weinstein,, S. Mirrett,, L. G. Reimer,, R. J. Feldman,, C. R. Chuard,, and L. B. Reller. 1995. Controlled evaluation of BacT/Alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. J. Clin. Microbiol. 33: 2265– 2270.

172. Wilson, M. L.,, M. P. Weinstein,, L. G. Reimer,, S. Mirrett,, and L. B. Reller. 1992. Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J. Clin. Microbiol. 30: 323– 329.

173. Yeo, S. F.,, Y. Zhang,, D. Schafer,, S. Campbell,, and B. Wong. 2000. A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum. J. Clin. Microbiol. 38: 1439– 1443.

174. Zwadyk, P., Jr.,, C. L. Pierson,, and C. Young. 1994. Comparison of Difco ESP and Organon Teknika BacT/Alert continuous-monitoring blood culture systems. J. Clin. Microbiol. 32: 1273– 1279.

175. Zwadyk, P., Jr.,, R. A. Tarlton,, and A. Proctor. 1977. Evaluation of the API 20C for identification of yeasts. Am. J. Clin. Pathol. 67: 269– 271.

Tables

Commercial Methods for Identification and Susceptibility Testing of Fungi

/content/10.1128/9781555817961.chap9.tab9-1

TABLE 1

Comparison of commercial methods for cryptococcal antigen testing

10.1128/9781555817961/tab9-1_thmb.gif

10.1128/9781555817961/tab9-1.gif

TABLE 1

Comparison of commercial methods for cryptococcal antigen testing

/content/10.1128/9781555817961.chap9.tab9-2

TABLE 2

Comparison of commercial methods for C. albicans antigen testing

10.1128/9781555817961/tab9-2_thmb.gif

10.1128/9781555817961/tab9-2.gif

TABLE 2

Comparison of commercial methods for C. albicans antigen testing

/content/10.1128/9781555817961.chap9.tab9-3

TABLE 3

Comparison of Isolator method (Wampole) with other blood culture methods and systems

10.1128/9781555817961/tab9-3_thmb.gif

10.1128/9781555817961/tab9-3.gif

TABLE 3

Comparison of Isolator method (Wampole) with other blood culture methods and systems

/content/10.1128/9781555817961.chap9.tab9-4

Table 4

Comparison of commercial fungal identification methods

10.1128/9781555817961/tab9-4_thmb.gif

10.1128/9781555817961/tab9-4.gif

Table 4

Comparison of commercial fungal identification methods

/content/10.1128/9781555817961.chap9.tab9-5

Table 5

Agreement of methods for susceptibility testing of yeasts

10.1128/9781555817961/tab9-5_thmb.gif

10.1128/9781555817961/tab9-5.gif

Table 5

Agreement of methods for susceptibility testing of yeasts